support of the foundations:National Key R&D Program of China,Grant Nos.2022YFC2404201;CAS Project for Young Scientists in Basic Research,Grant Nos.YSBR-067;The Gusu Innovation and Entrepreneurship Leading Talents in Suzhou City,Grant Nos.ZXL2021425;Jiangsu Science and Technology Plan Program,Grant Nos.BK20220263;National Key R&D Program of China,Grant Nos.2021YFF0700503.
There is a certain failure rate in traditional glaucoma surgery because of the lack of depth information in microscope images.In this work,we present a digital microscope-integrated optical coherence tomography(MIOCT)...
supported by grants from the Program for Zhejiang Leading Talent of S&T Innovation(No.2021R52012);the Key Research and Development Projects of Zhejiang Province(No.2022C03112);the Wenzhou Innovation Team.
To the Editor:Glaucoma is a leading cause of irreversible blindness worldwide.[1]Trabeculectomy with mitomycin C(MMC)has been the standard surgical intervention for reducing intraocular pressure(IOP)and slow down the ...
Dear Editor,We have treated two patients of glucocorticoid-induced glaucoma with penetrating canaloplasty(PCP)since 2021.PCP is a new type internal drainage surgery for glaucoma,which is a bleb-independent filtering s...
National Natural Science Foundation of China(No.82201177);Health Commission of Zhejiang Province(No.2023KY914);Key R&D Program of Zhejiang(No.2022C03112);National Key R&D Program of China(No.2020YFC2008200);Zhejiang Provincial National Science Foundation of China(No.LQ18H120010);Zhejiang Health Innovation Talents Program(No.2016025);Key Innovation and Guidance Program of the Eye Hospital,School of Ophthalmology&Optometry,Wenzhou Medical University(No.YNZD2201903);Wenzhou Municipal Technological Innovation Program of High-level Talents(No.604090352/577).
Glaucoma is one of the most common optic neuropathies,featuring progressive retinal ganglion cell damage and visual field loss(Tham et al.,2014;Xu et al.,2020).Currently,the only effective treatment for this condition...
Supported by National Key Research and Development Project of China (No.2020YFC2008200);Program for Zhejiang Leading Talent of S&T Innovation (No.2021R52012);Key Research and Development Projects of Zhejiang Province (No.2022C03112);Zhejiang Provincial Program for the Cultivation of Leading Talents in Colleges and Universities (No.2020099)。
AIM: To report the outcomes of penetrating canaloplasty for corticosteroid-induced glaucoma in a case series.METHODS: Penetrating canaloplasty is a blebindependent filtering surger y unifying canaloplasty and trabecul...
Acquired atresia of the external auditory canal(EAC)is a rare cause of conductive hearing loss.It has been traditionally classified into 4 categories:traumatic,post-operative,neoplastic and inflammatory.Post-inflammat...
As a non-penetrating glaucoma surgery(NPGS), canaloplasty aims to reconstruct the physiological outflow of aqueous humor by dilating the Schlemm’s canal. Ab interno canaloplasty(ABiC), which can reconstruct the natur...
Background:The aim of this study is to review the outcomes of canaloplasty versus canaloplasty combined with phacoemulsification in a retrospective cohort study and to evaluate the efficacy of these methods in terms o...
Glaucoma is the second leading cause of blindness in the world and a group of diseases of the optic nerve involving loss of retinal ganglion cells in a characteristic pattern of optic neuropathy.Gene, environment and ...
Supported by Fujian Provincial Science and Technology Department (No.2014Y4003)
AIM: To present a new, simple, inexpensive Schlemm canal microcatheter for circumferential canaloplasty in a rabbit model. METHODS: A rabbit glaucoma animal model was established by intravitreal injection of triamci...